专利检索 ap:("Takeda Pharmaceutical Company Limited") AND inv:"Robert RUBENS" 第 1 页

1.

发明申请
USE OF AN OREXIN 2 RECEPTOR AGONIST FOR THE TREATMENT OF EXCESSIVE SLEEPINESS 有权

公开(公告)号：US20220331303A1

公开(公告)日：2022-10-20

申请号：US17642337

申请日：2020-09-12

申请人： Takeda Pharmaceutical Company Limited

发明人： Deborah HARTMAN , Rebecca EVANS , Helene FAESSEL , Robert RUBENS , Shinichiro TANAKA

IPC分类号： A61K31/445 , A61P25/26 , A61K45/06

摘要： Described herein are methyl 3-((methylsulfonyl)amino)-2-(((4-phenylcyclohexyl)oxy)methyl)-piperidine-1-carboxylate (Compound (I)), compositions comprising Compound (I), and the use of Compound (I) for the treatment of excessive sleepiness in a subject in need thereof.